The impact of socio‐economic deprivation on the long‐term survival of people with diabetes and acute myocardial infarction: A nationwide cohort study

Figures

• 

  FIGURE 1. STOBE diagram detailing study inclusion and exclusion criteria.

• 

  FIGURE 2. Unadjusted and adjusted survival curves for diabetes mellitus patients with AMI according to socio‐economic status. Adjusted survival calculated from Cox model adjusting for age, sex, year, hospital region, heart rate, blood pressure, comorbid conditions (hypertension, history of asthma or COPD, history of CVA or PVD, hypercholesterolaemia, family history of coronary artery disease, smoking history, previous AMI, previous PCI and previous CABG), cardiac arrest, LV systolic function, Killip classification and ischaemic ECG changes, medication strategy (warfarin, LMWH, UFH, glycoprotein B3A, aspirin, P2Y12 inhibitor, statin, beta‐blockers and ACE inhibitors), invasive angiography while an inpatient and revascularisation by PCI or CABG.

• 

  FIGURE 3. Unadjusted and adjusted survival curves for all AMI patients without diabetes mellitus according to socio‐economic status. Adjusted survival calculated from Cox‐model adjusting for age, sex, ethnicity (classified according to the MINAP categories; White, Black, Asian, Mixed and Other), year of admission, hospital region, admission heart rate, admission systolic blood pressure, comorbid conditions (hypertension, history of asthma or chronic obstructive pulmonary disease (COPD), history of cerebrovascular accident (CVA) or peripheral vascular disease (PVD), hypercholesterolaemia, family history of coronary artery disease, smoking history, previous AMI, history of angina, history of previous PCI and previous CABG), medication strategy (aspirin, P2Y12 inhibitor, LMWH, fondaparinux, warfarin, unfractionated heparin (UFH), glycoprotein B3A, ACE inhibitor/ARB, statin, beta‐blocker), cardiac arrest, left ventricular (LV) systolic function, Killip classification and ischaemic ECG changes and invasive coronary angiography, revascularisation by percutaneous coronary intervention (PCI) or coronary artery bypass grafts surgery (CABG).

• 

  FIGURE 4. Margins plot showing interaction between diabetes status and IMD deprivation quintile on probability of 1‐year mortality. Adjusted 1‐year mortality calculated from logistic regression model, adjusting for age, sex, ethnicity (classified according to the MINAP categories; White, Black, Asian, Mixed and Other), year of admission, hospital region, admission heart rate, admission systolic blood pressure, comorbid conditions (hypertension, history of asthma or chronic obstructive pulmonary disease (COPD), history of cerebrovascular accident (CVA) or peripheral vascular disease (PVD), hypercholesterolaemia, family history of coronary artery disease, smoking history, previous AMI, history of angina, history of previous PCI and previous CABG), medication strategy (aspirin, P2Y12 inhibitor, LMWH, fondaparinux, warfarin, unfractionated heparin (UFH), glycoprotein B3A, ACE inhibitor/ARB, statin, beta‐blocker), cardiac arrest, left ventricular (LV) systolic function, Killip classification and ischaemic ECG changes, and invasive coronary angiography, revascularisation by percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG).